Skip to content

Cellulite treatment using the Aveli device: A pilot, feasibility trial.

Cellulite treatment for cosmetic thigh treatment in women with moderate-severe cellulite using the Aveli device: A feasibility trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12623000582651
Acronym
The STRIVE Study
Enrollment
20
Registered
2023-05-29
Start date
2023-01-04
Completion date
2023-05-03
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is a prospective, pilot trial with two study groups. Group 1 will undergo cellulite treatment on their thighs with optional buttock treatment with the Avéli device. Group 2 will undergo the combined procedure of Avéli treatment for cellulite with fat grafting on their thighs with optional buttock treatment.

Interventions

Group 1 participants will undergo treatment on their thighs with optional buttock treatment with the Avéli procedure. Group 2 participants will undergo a combined procedure of Avéli with small volume fat grafting. The Avéli precision cellulite release device is a manual instrument intended to separate tissue (manner for the reduction in the appearance of cellulite). The Investigator will allocate participants to Group 1 or group 2 per the inclusion/exclusion criteria. Any candidates enrolled in

Group 1 participants will undergo treatment on their thighs with optional buttock treatment with the Avéli procedure. Group 2 participants will undergo a combined procedure of Avéli with small volume fat grafting. The Avéli precision cellulite release device is a manual instrument intended to separate tissue (manner for the reduction in the appearance of cellulite). The Investigator will allocate participants to Group 1 or group 2 per the inclusion/exclusion criteria. Any candidates enrolled in Group 2 must have a suitable fat donor site. A minimum of 5 participants must be enrolled in each group.

Sponsors

Revelle Aesthetics Pty Ltd
Lead SponsorCommercial sector/Industry

Study design

Allocation
Non-randomised trial
Intervention model
Other
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
21 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1.Female 21-55 years 2.Moderate to severe cellulite on the thighs, or, if applicable buttocks 3.Minimum of 5 depressions on the thigh(s) 4.BMI < 35

Exclusion criteria

1.In the last 12 months, underwent a cellulite treatment on the buttocks and/or thighs 2.Previous liposuction on the buttocks and/or thighs 3.Greater than 10% increase or decrease in body weight within the last six (6) months or any history of weight loss greater than 60 kg 4.Tattoo or former tattoo in the treatment area 5.Physician assessed severe skin laxity, flaccidity, and/or sagging in targeted cellulite treatment regions

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026